Interferon Beta Use and Disability Prevention in Relapsing-Remitting Multiple Sclerosis

被引：7

作者：

Greenberg, Benjamin M. ^{[1
]}

Balcer, Laura ^{[3
]}

Calabresi, Peter A. ^{[4
]}

Cree, Bruce ^{[5
]}

Cross, Anne ^{[7
]}

Frohman, Teresa ^{[1
]}

Gold, Ralf ^{[8
]}

Havrdova, Eva ^{[12
]}

Hemmer, Bernhard ^{[9
]}

Kieseier, Bernd C. ^{[10
]}

Lisak, Robert ^{[13
]}

Miller, Aaron ^{[14
]}

Racke, Michael K. ^{[15
]}

Steinman, Lawrence ^{[6
]}

Stuve, Olaf ^{[1
]}

Wiendl, Heinz ^{[11
]}

Frohman, Elliot ^{[1
,2
]}

机构：

[1] Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75235 USA

[2] Univ Texas SW Med Ctr Dallas, Dept Ophthalmol, Dallas, TX 75235 USA

[3] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA

[4] Johns Hopkins Univ Hosp, Dept Neurol, Baltimore, MD 21287 USA

[5] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA

[6] Stanford Univ, Dept Neurol, Stanford, CA 94305 USA

[7] Washington Univ, Dept Neurol, St Louis, MO USA

[8] Ruhr Univ Bochum, Dept Neurol, Bochum, Germany

[9] Univ Munich, Dept Neurol, D-80539 Munich, Germany

[10] Univ Dusseldorf, Dept Neurol, Dusseldorf, Germany

[11] Univ Munster, Dept Neurol, D-48149 Munster, Germany

[12] Charles Univ Prague, Dept Neurol, Prague, Czech Republic

[13] Wayne State Univ, Dept Neurol, Detroit, MI USA

[14] Mt Sinai Sch Med, Dept Neurol, New York, NY USA

[15] Ohio State Univ, Dept Neurol, Columbus, OH 43210 USA

来源：

JAMA NEUROLOGY | 2013年 / 70卷 / 02期

基金：

美国国家卫生研究院;

关键词：

PLACEBO-CONTROLLED TRIAL; PROGRESSION;

D O I：

10.1001/jamaneurol.2013.1017

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

[No abstract available]

引用

页码：248 / 251

页数：4

共 50 条

[1] The use of interferon beta in relapsing-remitting multiple sclerosis
Etheridge, LJ
Beverley, DW
Ferrie, C
McManus, E
[J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2004, 89 (08) : 789 - 791
[2] Interferon-beta and disability progression in relapsing-remitting multiple sclerosis
Drulovic, Jelena
Kostic, Jelena
Mesaros, Sarlota
Basuroski, Irena Dujmovic
Stojsavljevic, Nebojsa
Kisic-Tepavcevic, Darija
Pekmezovic, Tatjana
[J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2013, 115 : S65 - S69
[3] Association Between Use of Interferon Beta and Progression of Disability in Patients With Relapsing-Remitting Multiple Sclerosis
Shirani, Afsaneh
Zhao, Yinshan
Karim, Mohammad Ehsanul
Evans, Charity
Kingwell, Elaine
van der Kop, Mia L.
Oger, Joel
Gustafson, Paul
Petkau, John
Tremlett, Helen
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (03): : 247 - 256
[4] Interferon beta-1a in relapsing-remitting multiple sclerosis
Blumhardt, L
[J]. HOSPITAL MEDICINE, 1999, 60 (03): : 192 - 195
[5] Impact of beta-interferon on disability progression in relapsing-remitting multiple sclerosis: a Bayesian analysis
O'Rourke, K.
Walsh, C.
Hutchinson, M.
[J]. JOURNAL OF NEUROLOGY, 2006, 253 : 102 - 103
[6] PROGNOSIS OF DISABILITY IN RELAPSING-REMITTING MULTIPLE SCLEROSIS
Somilo, O., V
Kalbus, O., I
Makarov, S. O.
Sorokin, A. V.
Shastun, N. P.
[J]. WORLD OF MEDICINE AND BIOLOGY, 2023, 84 (02): : 147 - 152
[7] Disability trajectories in relapsing-remitting multiple sclerosis
Uher, T.
Horakova, D.
Havrdova, E. Kubala
Izquierdo, G.
Eichau, S.
Patti, F.
Prat, A. P.
Girard, M.
Duquette, P.
Grammond, P.
Onofrj, M.
Lugaresi, A. L.
Bergamaschi, R.
Ozakbas, S.
Grand'Maison, F.
Hupperts, R.
Sola, P.
Ferraro, D.
Sa, M. J.
Kalincik, T.
[J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 813 - 814
[8] Impact of discontinuing interferon beta in patients with relapsing-remitting multiple sclerosis
Agiela, Mabroka I. M.
[J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (06) : NP5 - NP5
[9] Predicting beta-interferon failure in relapsing-remitting multiple sclerosis
O'Rourke, K.
Walsh, C.
Antonelli, G.
Hutchinson, M.
[J]. MULTIPLE SCLEROSIS JOURNAL, 2007, 13 (03) : 336 - 342
[10] Profile of PEGylated interferon beta in the treatment of relapsing-remitting multiple sclerosis
Cocco, Eleonora
Marrosu, Maria Giovanna
[J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 : 759 - 766

← 1 2 3 4 5 →